General Information of the Compound
| Compound ID |
CP0103476
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(R)-6-Methylamino-6,7,8,9-tetrahydro-5H-carbazole-3-carboxylic acid amide
Show/Hide
|
||||||||||||||||||
| Synonyms |
(3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide
(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide
(R)-5,6,7,8-Tetrahydro-6-(methylamino)carbazole-3-carboxamide
Allegro
Allergo filmtabletten
Allergo filmtabletten(TN)
Auradol
Frova
Frova (TN)
Frovatriptan
Frovatriptan (INN)
Frovelan
Migard
Miguard
Rilamig
SB 209509
SB-209509
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C14H17N3O
|
||||||||||||||||||
| Molecular Weight |
243.31
|
||||||||||||||||||
| Canonical SMILES |
CN[C@@H]1CCc2[nH]c3ccc(cc3c2C1)C(N)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C14H17N3O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18)/t9-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
XPSQPHWEGNHMSK-SECBINFHSA-N
|
||||||||||||||||||
| CAS |
158747-02-5
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound